Could a simple steroid ease Post-C-Section pain?
NCT ID NCT07257406
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This study looked at whether giving a single dose of the steroid dexamethasone after a cesarean delivery can reduce pain and improve recovery. 87 women who had a planned C-section under spinal anesthesia received either dexamethasone or a placebo right after delivery. Researchers measured pain scores when patients first got out of bed, about 6 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Dexamethasone
- What this could lead to
- If effective, this could offer a low-cost, low-side-effect option to improve pain control after cesarean delivery.
- What could go wrong
- This is a small, completed trial with 87 participants, so results may not apply to all patients. Dexamethasone may not significantly reduce pain compared to standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
87 people
The number who actually took part.
- Started
-
Sep 2018
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years * Cesarean delivery * Planned spinal or combined neuraxial anesthesia * Presence of an investigator in the delivery room * Pregnancy \> 34 weeks gestation Exclusion Criteria: * Cesarean delivery under general anesthesia * Inability to understand French or English * Allergy or hypersensitivity to dexamethasone * Allergy to hydromorphone * Allergy to NSAIDs * Acute kidney injury or chronic kidney failure * Preeclampsia * Extremely urgent cesarean section * Urgent cesarean section with non-reassuring fetal monitoring * Known maternal heart disease * High-grade placental abnormality * Diabetes (pregnancy or pre-existing) * Systemic infection, sepsis, fever * Regular use of dexamethasone in the last year * Weight greater than 120 kg and less than 70 kg * Height less than 150 cm * Chronic pain and/or chronic use of opioids
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cesarean delivery are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Sainte-Justine
Montreal, Quebec, H2V 4K8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- How much lidocaine reaches a newborn during an urgent C-Section?
- Could pregnant patients skip clinic visits and monitor their baby from home?
- Can a common steroid stretch spinal anesthesia and keep surgery patients comfortable longer?
- Can a video session get pregnant women to seek more health care?
- Citrulline: a potential key to prolonging pregnancy in pre-eclampsia?
- Can virtual reality coach pregnant women toward healthier habits?